WASHINGTON -- Doctors may soon have two new drug options to treat patients with hepatitis C, just as the liver-destroying virus becomes a major public health issue for millions of Americans reaching retirement age. The Food and Drug Administration holds a public meeting this week to review two experimental medications from two U.S.

Topics:  washington    doctors   americans   the food   drug administration    johnson   gilead   sciences   u.s    johnson   drugs   hepatitis   public   
BING NEWS:
  • New uses for existing drugs could help combat antimicrobial resistance
    Both drugs showed notable antibacterial effects ... with a low toxicity profile and a reduced likelihood of promoting resistance, a promising outcome in the search for new ways to tackle hard-to-treat ...
    11/17/2024 - 11:00 am | View Link
  • Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
    Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a strong buy amid high cash burn.
    11/15/2024 - 8:26 am | View Link
  • Positive Outlook for Nuvectis Pharma: Promising Clinical and Preclinical Developments Justify Buy Rating
    H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Nuvectis Pharma (NVCT – Research Report) today and set a price target ...
    11/14/2024 - 7:28 pm | View Link
  • Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments
    Early studies show promising results, suggesting these new drugs could offer more effective and reliable treatments for mental health and neurological conditions. As research progresses, these ...
    11/12/2024 - 1:32 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News